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ABSTRACT
Motivation: Understanding the structure and interplay of cellular
signalling pathways is one of the great challenges in molecular
biology. Boolean Networks can infer signalling networks from
observations of protein activation. In situations where it is difficult
to assess protein activation directly, Nested Effect Models are
an alternative. They derive the network structure indirectly from
downstream effects of pathway perturbations. To date, Nested
Effect Models cannot resolve signalling details like the formation
of signalling complexes or the activation of proteins by multiple
alternative input signals. Here we introduce Boolean Nested Effect
Models (B-NEM). B-NEMs combine the use of downstream effects
with the higher resolution of signalling pathway structures in Boolean
Networks.
Results: We show that B-NEMs accurately reconstruct signal flows
in simulated data. Using B-NEM we then resolve BCR signalling via
PI3K and TAK1 kinases in BL2 lymphoma cell lines.
Availability: R code is available at https://github.com/MartinFXP/B-
NEM (github). The BCR signalling dataset is available at the
GEO database (http://www.ncbi.nlm.nih.gov/geo/) through accession
number GSE68761.
Contact: Martin-Franz-Xaver.Pirkl@ukr.de, Rainer.Spang@ukr.de
Supplementary information: Supplementary data are available at
Bioinformatics online.
1 INTRODUCTION
Cells process input signals to output signals using a network of
cellular signalling pathways. For example, a small molecule binds a
membrane receptor. The signal is brought into the cell via structural
modification of the receptor. A set of kinases and other signalling
molecules propagate the signal through the cytosol. This involves
both activation and repression of proteins. Often complexes of
multiple proteins must form before a signal propagates. Some of
the molecules are also part of different pathways linking multiple
pathways together. Eventually, the signal enters the nucleus where
transcription factors and chromatin remodelling enzymes become
activated. Finally, the combination of activated transcription factors
and regulatory co-factors leads to the transcription of a large
set of genes changing the phenotype of the cell. Understanding
the structure and the interplay of pathways is crucial both for
understanding the cellular mechanism and for designing novel
to whom correspondence should be addressed
therapies that target specific pathways.
Inferring networks from molecular profiles is a well developed field
in bioinformatics. Transcriptional data can be generated more easily
compared to protein activation data. Consequently, many algorithms
were developed that focus on the reconstruction of regulatory
networks. E.g. Gaussian graphical models (GGM) (Scha¨fer &
Strimmer, 2005), Bayesian networks (Friedman et al. , 2000),
the PC-algorithm (Kalisch & Bu¨hlmann, 2007) or the Algorithm
for the Reconstruction of Accurate Cellular Networks (ARACNE,
Margolin et al. , 2006). All these methods use observational gene
expression data to construct regulatory networks based on different
association scores between genes.
It is no problem to quantify the expression of any gene
using standard methods like qPCR, microarrays, or RNAseq.
Observing signalling networks is more complicated. Protein
activation can operate on the levels of protein expression, cellular
protein localization, or protein modifications like phosphorylation,
ubiquitination etc. While there are assays to assess activation on
any of these levels, those assays are more elaborate, more expensive
and less generic. Moreover, for every protein a priori information
on which type of modification mediates signal transduction is
necessary.
Molecular biologists have been inferring pathways without formal
computations for many years. Typically functional/interventional
data is used. Pathways are perturbed by activation or inhibition
of genes and the consequences of the interventions are observed,
organized and interpreted. Also a range of algorithms have been
described that formalise these types of arguments and make them
accessible to bigger and more complex pathway models.
Sachs et al. , 2005 use flow cytometry data from perturbation
experiments to infer protein signalling pathways with a Bayesian
network approach. They test for conditional independence between
proteins’ states using protein inhibition experiments and direct
measurement of these states.
Markowetz et al. , 2005 introduced Nested Effects Models (NEM)
(Markowetz et al. , 2007; Froehlich et al. , 2011; Niederberger
et al. , 2012). NEMs infer non-transcriptional signalling pathways
by transcriptional downstream effects of pathway perturbation. A
pathway is activated in a set of cellular assays where specific
pathway components are silenced. The silencing of a specific
component blocks the flow of information in a specific branch of the
pathway. As a consequence, genes that normally change expression
in response to the stimulus no longer react in inhibition assays.
NEMs infer the pathway structure from the nesting of these sets:
if the effected genes of perturbing gene B are a noisy subset of the
effected genes of gene A, then A is upstream of B. This concept has
been extended to time series data (Anchang et al. , 2009; Froehlich
et al. , 2011; Du¨mcke et al. , 2014), evolving networks (Wang et al. ,
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2014), and network inference with hidden confounders (Sadeh et al.
, 2013).
To date NEMs can infer the upstream/downstream relations of
genes in a pathway (Markowetz et al. , 2005), they can distinguish
activation from repression (Vaske et al. , 2009) and they can
resolve the flow of information (Anchang et al. , 2009; Froehlich
et al. , 2011). However they cannot model the role of complex
formation in signalling pathways. If a protein X is activated by
a complex, all members of the complex must be present and in
the correct activation state. The proteins in the complex operate
concertedly and are linked to X by an AND gate. In another
scenario, X can be activated independently by several proteins.
In this case the proteins are linked by an OR gate. Boolean
Networks (Kauffman, 1969) model logical gates. They have been
used to simulate signalling pathways (Klamt et al. , 2007) and to
reconstruct them from interventional data (Saez-Rodriguez et al. ,
2009). Allowing for logical gates leads to identifiability problems of
network structures. To resolve this ambiguities, prior knowledge on
the pathway structures is used. Saez-Rodriguez et al. , 2009 describe
an algorithm called CellNetOptimizer (CNO) to construct signalling
pathways from directly observed activation states of proteins in
the Boolean Network framework. They combine prior knowledge
networks, with protein phosphorylation data form interventional
assays.
Here we describe Boolean Nested Effect Models (B-NEM). This
method combines advantages from Boolean Network Models and
Nested Effect Models. Like Boolean Networks B-NEMs distinguish
between the alternative and cooperative activation of a protein,
and like normal NEMs, B-NEMs do not need direct observations
of protein activity. Moreover, B-NEMs can use data from assays
where several pathway genes are perturbed simultaneously. In the
following, we will describe the model formalism and define a
pathway score together with a genetic algorithm to search for high
scoring networks. We will then validate our algorithm on simulated
data and use it to analyse B-cell receptor (BCR) signalling in
lymphoma cells.
2 BOOLEAN NESTED EFFECTS MODELS
2.1 Pathway model and score
Signalling Pathways and Deterministic Boolean Networks Molecular
signalling pathways can be described as Deterministic Boolean Networks
(Saez-Rodriguez et al. , 2009). Networks are encoded as directed acyclic
hyper-graphs 	 = (S;H) consisting of a set of nodes S = (S1; : : : ; SN )
and a set of Hyper-edges H = (H1; : : : HM ). Every node Si represents a
signalling protein that can be either active (Si = 1) or inactive (Si = 0).
Hyper-edges describe how the signal is propagated through the network.
Every directed hyper-edge Hj connects one or more parent nodes with a
single child node. Hyper-edges with one parent node specify whether the
child is activated or repressed by its parent. Hyper-edges with more parents
specify a unique activation pattern of the parent nodes that is required for
activating the child. If a node has multiple incoming hyper-edges, it can
be independently activated by all of them. Hence, every hyper-edge with
more then one parent node encodes an AND gate and multiple hyper-edges
with the same child form OR gates (Figure 1). Signalling pathways form
AND gates, if multiple proteins need to be jointly activated to propagate the
signal to their target molecule. This is often associated with the formation
of larger protein complexes. OR gates in contrast occur when signalling is
organized in a redundant manner. As with Bayesian networks and nested
effects models, we assume that the real graph is acyclic. This limits the
scope of the method to models of signalling pathways in which the signal
is propagated from receptors via branching cytosolic effector pathways into
the nucleus without feedback loops.
Experimental design and data Our goal is to estimate the signalling
pathway model 	 from a dataset D. The data consist ofK gene expression
profiles (D(1); : : : ; D(K)) from a set of functional assays with specific
perturbations of the pathway. We assume that the expression data is on
a logarithmic scale. Perturbations include the exogenous stimulation of
pathway receptors and the inhibition of signalling components. Every profile
D(k) is hence associated with a specific experimental condition C(k) that
specifies which receptors were stimulated and which signalling genes were
inhibited. This is the typical experimental set-up of Nested Effect Models
(NEM) (Markowetz et al. , 2005, 2007). Following the NEM literature, we
call the signalling pathway components S1; : : : Sn S-Genes and the genes
that show expression changes in response to perturbations E-Genes. S-genes
and E-genes can but need not overlap.
Expected and Observed Response Schemes For a given hyper-graph
	 and a given condition C(k), we can calculate the activation states
of all nodes in 	 as follows: (1) root nodes are initialized to zero, (2)
stimulated nodes are set to 1 and inhibited nodes are set to 0 independently
of any incoming signals from parent nodes, (3) all other nodes are
determined by propagating activation states through the directed acyclic
graph using the Boolean functions defined by the hyper-edges of 	. Let
C = (C(1); :::; C(K)) be the set of all experimental conditions, and
A  C  C a set of comparisons between pairs of conditions. For every
pair of conditions i = (C(k); C(l)) 2 A we can determine, whether the
expected activation of an S-gene is identical under both conditions or not.
We set ij = 0, if the predicted state of Sj is identical under Ck and Cl.
We set ij = 1, if Sj was switched on, i.e if it is inactive under Ck but
active under Cl and we set ij =  1, if Sj was switched off. We call 
the Expected S-gene Response Scheme (ERS) of 	 (Figure 1, middle).
Analogously, we organize the observed E-gene responses. For a given E-
gene Ej , let i;j be the expression change of Ej in comparison i. We call
 the Observed E-gene Response Scheme (ORS).
Scoring hyper-graphs For a given hyper-graph	, we want to score how
well its expected S-gene responses  match the observed E-gene responses
. This cannot be done directly, because  refers to activation states of
S-genes, while  refers to downstream effects in E-genes. Following the
nested effect model literature (Markowetz et al. , 2005; Tresch &Markowetz,
2008), we assign E-genes to S-genes. For every E-gene E we search for
the S-gene S(E) for which the expected S-gene responses (S) matches
observed E-gene responses (E) best. We quantify this match by the
absolute value of the rank correlation between expected S-gene and the
observed E-gene responses. Finally, we score the hyper-graph by balancing
its data fit with its size:
L(	) = 1
m

X
E
j((S(E));(E))j     1
M

X
H2	
#pa(H) (1)
The first sum runs over all E-genes and the second sum runs over all hyper-
edges in 	. (x; y) is the rank correlation of x and y, #pa(H) is the
number of parent nodes of hyper-edge H .  > 0 is a parameter to calibrate
the penalty for network size. The network size penalty is identical to that
used in Saez-Rodriguez et al. , 2009. m is the number of E-genes used in
the score and M is the maximal network size possible. This way the score
normalizes to [0; 1] and the size penalty to [0; ]. This makes  independent
of the number of E-genes or the overall size of the fully connected network.
2.2 Restricting the search space using prior knowledge
Like Bayesian networks and standard NEMs, also B-NEMs are affected by
likelihood/score equivalence. It is possible that two different networks have
the same expected S-gene response scheme . If in addition the networks
have identical size, they yield identical scores no matter what the data looks
like. If not the smaller network is chosen. Note that  depends on the design
of the set of perturbation assays C. Two networks can be distinguished by
one experimental design but not by another. Figure 2 gives an example, how
2
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Fig. 1. Hyper-graphs and their response schemes The two matrices are an expected S-gene response scheme of the S-genes and a hypothetical noisy
continuous observed E-gene response scheme of attached E-genes for the hyper-graph left. Black matrix entries indicate up-regulation (+1), white down-
regulation (-1) and gray no change (0). Each column is a response scheme of an S-gene respectively E-gene. The rows are comparisons between two conditions.
In a condition+ denotes the activation of the S-gene and  the inhibition independent of the state of the parents. The set of modelled comparisons is restricted
to the typical design of a nested effect model. Included are comparisons of stimulation vs. control and stimulations + inhibitions vs. stimulations only. S0 is a
receptor that can be activated. The other S-genes propagate the signal and can be inhibited. The edgeH4 is an AND gate with two parents. S4 is activated by
H4, if S1 is active and S2 inactive. Alternatively, the inhibition of S3 can activate S4. HenceH4 andH5 implicitly form an OR gate.
the design can (a) affect score equivalence classes and (b) affect the optimal
scoring network. Interestingly we need an experiment involving only S3
during stimulation of S0 to correctly identify the signalling logic of S4.
If the data can not distinguish between competing networks it is still possible
that existing domain knowledge can. Like Saez-Rodriguez et al. , 2009 we
represent pathway knowledge by a priori restrictions of the network search
space. With this restrictions we do not only reduce network ambiguity due
to score equivalence, but also ensure that the constructed networks follow
general conventions of modelling signalling pathways (e.g. the signal is
propagated from receptors, via cytosolic molecules to nuclear factors). We
encode prior knowledge by a directed graph G whose edges are a collection
of all links between S-genes that are a priori possible. In other words, it is
the missing edges ofG that define the search space restriction. We refer toG
as a Prior Knowledge Network (PKN). PKNs are then extended to a Boolean
network by adding hyper-edges such that all Boolean functions allowed in G
are a priori possible. Hence, while B-NEMs use help from prior knowledge
to estimate the network structure they infer logical gates only from data.
Using prior knowledge can resolve score equivalence problems, but there is
no guarantee that it always does.
2.3 Network search
The size of the space of hyper-graphs that needs to be searched is 2n, where
n is the number of hyper-edges in the extended PKN. Even for small PKN
an exhaustive search is hence impractical. Here we use a genetic algorithm
(Saez-Rodriguez et al. , 2009) involving tournament selection (Sokolov
& Whitley, 2005) and complementary insertion (Louis & Rawlins, 1992)
Details are given in the supplement, section 1.
Running time of the GA can be a limiting factor. It is determined by the size
of the search space. The more hyper-edges we exclude a priori, the smaller
the search space and the faster algorithm. For n = 504 our algorithm runs
less than 10 hours on an Intel(R) Xeon(R) CPU E5-4620 0 @ 2.20GHz.
We now describe a generic way to construct PKNs that effectively reduce
the search space using prior knowledge that is often readily available. We
first limit the size of AND gates to two incoming nodes then we assign S-
genes uniformly to five hierarchical layers: stimuli, receptors, membrane
complexes, cytosolic signalling and nuclear signalling. Then we assume that
Fig. 2. Network equivalence and experimental designs The response
schemes of the two network differ only for the experiment marked by
the arrow. If that experiment was missing the response schemes would be
identical and the left network would score higher due to its smaller size no
matter what the data looks like.
it is known whether a gene is an activator or a repressor. We then exclude
a priori all edges that span more then two adjacent layers. This restricts the
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search space for a 30 node network to 504 hyper-edges. Of course, if more
specific domain knowledge is available, we can relax some of these generic
parameters like allowing for larger complexes modelled by AND gates with
more then two parents or edges spanning more than two layers.
3 SIMULATIONS
Before applying B-NEM in practice we check whether the algorithm
can reconstruct networks accurately, if the data is generated from
known Boolean networks. We refer to underlying data generating
networks as Ground Truth Networks (GTN). GTNs and matching
PKNs are generated by randomly sampling edges from a super
PKN shown in the supplement, figure S3. The super PKN has 30
nodes and 144 edges respectively 504 hyper-edges after extension.
The nodes fall onto five layers representing ligands, receptors,
membrane complexes, cytosolic and nuclear signalling. Edges
connect nodes on adjacent layers. 90% of edges are stimulating
and 10% are inhibiting. We first draw a PKN and then a GTN.
To generate a network of n nodes we randomly choose n nodes
from the super PKN, ensuring that their is at least one node at every
layer. For this set of n nodes we take all hyper-edges connecting
those nodes as the extended PKN. From this PKN we randomly
sample 50% hyper-edges, but make sure that the network is at one
point stimulated. This means we reject GTNs which do not change
their state during any stimulation. Similarly we generate networks
of n hyper-edges. Without restricting the GTN to a specific number
of nodes. Finally 10 E-genes were attached to every S-gene. Note
that the PKN is always consistent with the GTN, no existing edges
are a priori excluded. For a given GTN and a set of conditions
we calculated the E-gene response scheme and added Gaussian
noise  N (0; ) with  2 f0:5; 1; 2g. Every E-gene profile was
generated in triplicates with independent noise. The experimental
conditions consist of controls, single and double stimulations,
single inhibitions and the single/double stimulations together with
single inhibitions. Finally, observed E-gene response schemes were
composed by the differences between controls and single/double
stimulations/inhibitions and the differences between single/double
stimulation and single/double stimulation with a single inhibition.
3.1 B-NEM accurately estimate the equivalence class of
networks with up to 30 S-genes.
We first tested the performance of B-NEM for GTNs with
10; 15; 20; 25 and 30 S-genes. For each size we generated 10
random GTNs and matching PKNs and run B-NEM on E-gene data
generated from these GTNs. The GTNs consisted of 10% of the
allowed edges in the corresponding PKN, hence the PKNs were
consistent with the GTN and effectively reduce the search space.
We then compared the expected S-gene response schemes of the
estimated networks with that of the GTNs. Figure 3, top shows the
sensitivity and specificity of the estimated networks (solid circle,
dashed triangle). The corresponding computation time is shown as
the dotted line connecting crosses. In this setting computation is
a limiting factor for networks with 30 genes, but reconstruction
accuracy is not.
3.2 Network reconstruction is sensitive to the strength
of the prior knowledge network.
In the previous simulation we checked whether the algorithm finds
the correct equivalence class of networks. However, equivalence
classes can be large and are hard to interpret. Due to score
equivalence multiple networks in the same equivalence class can
not be distinguished by data. However, equivalence classes can be
shrunk effectively by strong PKNs rendering network reconstruction
practical. Thus, we evaluated the accuracy of the estimated networks
as a function of the strength of the PKN. For 10 random GTNs
with 50 hyper-edges drawn randomly from the full PKN, we run
B-NEM using PKNs of 50; 164; 277; 390; 504 a priori possible
hyper-edges. Figure 3, bottom shows the sensitivity and specificity
of the reconstructed networks both on the level of expected S-gene
response schemes and the actual networks. While the performance
stays very good with respect to response schemes (equivalence
classes) it breaks down with respect to network reconstruction if
the PKN becomes weak.
If we do not allow for negative regulation, the PKN needn’t be a
DAG but can have cycles. Cycles in a PKN with negative regulation
can lead to undefined expected S-gene response schemes. See
supplement section 2 for details.
4 MODELLING B-CELL SIGNALLING
We now apply the B-NEM framework to a previously unpublished
dataset monitoring gene expression changes in the Burkitt
lymphoma cell line BL2 after induction of the B-cell receptor
(BCR). Our analysis explains how BCR signalling propagates to
downstream effector pathways like the NFB, MAP kinase, P38,
or JNK pathways through activation of the intermediate messengers
TAK1 and PI3K.
B-cell receptor signalling was induced in BL2 cells by cross-
linking IgM with an anti-IgM antibody. S-genes were inhibited
on protein level using small molecules: 5Z-7-oxozeaenol (TAK1),
IKK2 inhibitor VIII (IKK2), Ly294002 (PI3K), SB203580
(P38/MAPK14), SP600125 (JNK), U0126 (ERK1/2). In addition
to single inhibitions, IKK2, JNK and P38 were jointly inhibited
yielding three double and one triple inhibition. All inhibitions were
done in triplicate both under BCR stimulation and control conditions
and gene expression profiles were generated using Affymetrix
hgu133plus2 Genechips. Moreover, profiles of 6 negative controls
(unstimulated BL2 cells) and 6 positive controls (BCR stimulated
cells) were produced, yielding a dataset of 72 gene expression
profiles in total. The dataset was made available at the GEO database
under GSE68761.
The raw data was normalized (see supplement, section 3) and
observed E-gene response schemes were calculated for the
comparisons listed in table 1. We filtered for E-genes that respond
to BCR stimulation by at least an absolute log2 foldchange of 1 and
to another comparison by at least an absolute log2 foldchange of
log2(1:5)  0:58. This corresponds to a change in expression of at
least 100% respectively 50%, leaving us with 602 E-genes and their
continuous observed E-gene response scheme.
4.1 Prior knowledge in BCR signalling
The B-cell receptor (BCR) is the cell surface receptor that initiates
BCR signalling upon binding of an antigen. BCR signalling leads
to the activation of IKK2, P38, ERK, and JNK (DeFranco, 1997;
Richards et al. , 2001; Schuman et al. , 2009; Shinohara & Kurosaki,
2009). These four effector pathways send signals into the nucleus
that affect gene expression. The two proteins PI3K and TAK1 are
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Fig. 3. Simulation results From left to right we set  = 0:5; 1; 2 in each column respectively. Top: Random GTN of n nodes (x-axis) and the median
sensitivity, specificity of the ERS (solid circle, dashed triangle) and running time (dotted cross) for ten runs. The top axis shows the mean PKN size. Bottom:
Results for ten runs each given a fixed GTN and different PKN sizes (x-axis) including the GTN. Median sensitivity and specificity of the ERS (solid circle,
dashed triangle) and the hyper-edges (dotted cross, dashed-dotted x).
base level change level
(control) vs (BCR+)
(BCR+) vs (BCR+,PI3K-)
(BCR+) vs (BCR+,TAK1-)
(BCR+) vs (BCR+,ERK-)
(BCR+) vs (BCR+,IKK2-)
(BCR+) vs (BCR+,P38-)
(BCR+) vs (BCR+,JNK-)
(BCR+) vs (BCR+,IKK2-,P38-)
(BCR+) vs (BCR+,IKK2-,JNK-)
(BCR+) vs (BCR+,P38-,JNK-)
(BCR+) vs (BCR+,IKK2-,P38-,JNK-)
Table 1. Contrasts of conditions used to calculate the observed E-gene
response schemes from the data. + denotes activation of the node and  
inhibition in that particular condition.
potential mediators of BCR induced activation of effector pathways.
We do not put any restriction on the hierarchical ordering of PI3K
and TAK1. PI3K and TAK1 are parts of several other pathways
where they are described as activators and not as repressor of
signalling. We thus assume that the same holds true in BCR induced
signalling. What is not known is which activations depend on
which of the two mediators, nor is it known whether they activate
downstream pathways independently from each other (OR gate) or
jointly (AND gate). Furthermore the combinatorial inhibitions of
IKK2, P38 and JNK allow more freedom in the PKN and therefore
we do a complete reconstruction on this subnetwork. We summarize
this prior knowledge situation in the PKN of Figure 4.
4.2 Calibrating the sparseness parameter 
Calibrating  is critical to the performance of B-NEM.We randomly
split the set of E-genes in half. For various settings of  (exponential
decrease  2 1; 0:64; 0:36; 0:16; 0:04; 10 10; 0	) we learn a
network using the first half of the data (training set), and then score
this network using the second independent half (test set) but without
employing the complexity penalty in equation (1). We repeat this
step with 100 different random splits of E-genes and take the mean
of graph size, connected S-genes (both in percent) and scores of the
test sets. Figure 5 shows that the score continuously improves as 
approaches zero. For  = 0 the test accuracy drops again. Note that
for any positive zeta the smaller network wins in case of likelihood
equivalence while for  = 0 there is no size penalty operating at all.
We thus set  to 10 10.
4.3 The role of PI3K and TAK1
We run B-NEM on this data using the PKN and the parameter
settings described above. Figure 6 shows the highest scoring
network. The network predicts that the activation of the JNK
pathway is only PI3K dependent, while Erk is only TAK1
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Fig. 4. Prior search space restriction PKN for BCR signalling into IKK2,
P38, JNK and Erk. We do not allow for negative regulation. Naturally,
BCR defines the top S-gene. PI3K and TAK1 build the second hierarchical
layer but we additionally allow for TAK1 above PI3K or the reverse. The
third layer consists of IKK2, P38, JNK and ERK. Since our combinatorial
inhibitions reduce the problem of equivalence classes for IKK2, P38 and
JNK we allow for the complete reconstruction of the sub network consisting
of these three S-genes.
Fig. 5.  calibration Mean cross validated network scores as a function of
the complexity parameter . Score on the test dataset (solid circle, log-scale)
and graph size in percent (dashed triangle).
dependent. IKK2 activation is predicted either as redundant by PI3K
or alternatively TAK1. P38 is positively regulated by PI3K via either
JNK or alternatively jointly with IKK2. The signalflow to P38 can
be stopped either with the inhibition of PI3K or the double inhibition
of JNK and IKK2. The observed E-gene response schemes side by
side with the corresponding expected S-gene response schemes can
be seen in supplementary figures S5-S11.
That TAK1 alone, as proposed by our model, can not block
signalling into IKK2 and JNK has been detected for toll-like
receptor 8 (TLR8) signalling in mouse embryonic fibroblasts
(MEF, Qin et al. , 2006). TAK1 knock-out mice still showed an
activated NFB pathway. TLR8 also seems to be causative in some
lymphomas (Ngo Vu N. et al. , 2011). Furthermore Matta et al. ,
2012 show that herpes virus encoded viral FLICE inhibitory protein
(vFLIP) K13 inducted NFB activity is not impaired in TAK1
deficient MEFs. Chen & Debnath, 2013 give evidence that the IKK
Fig. 6. Learned network The highest scoring network (black edges). The
BCR signal is propagated via PI3K into JNK and P38. IKK2 is alternatively
regulated by PI3K or TAK1. PI3K and TAK1 are directly regulated by
BCR. TAK1 propagates the signal into the ERK pathway. Additionally
P38 is alternatively regulated by JNK or IKK2. The different AND and
OR gates are annotated more prominently. Grey dashed edges illustrate
the propagation of signals from all molecules into the nucleus to regulate
transcription.
complex (IKK1, IKK2, NEMO) acts independently of PI3K in
mammary epithelial cells and Xue et al. , 2000 that ERK can be
activated independently from PI3K in nerve growth factor (NGF)-
dependent sympathetic neurons. Kloo et al. , 2011 propose the
regulation of IKK2 by PI3K in diffuse large B-Cell like lymphomas.
They show in their data, that the PI3K inhibitor only partially blocks
IKK2 inhibitor target genes I.e. downstream targets of PI3K are
a subset of downstream targets of IKK2, which is not true in our
case. In the Nested Effects Model logic this either places PI3K
downstream of IKK2 or PI3K and IKK2 have joint downstream
targets. A third explanation is, that some NFB activity is regulated
by PI3K, but another alternative regulation is possible as depicted in
our network in figure 6.
As a comparison we applied the original NEM to the data
(supplement section 4).
5 DISCUSSION
We have introduced B-NEM a novel method to infer signalling
network structures. B-NEM extends the framework of standard
nested effect models. Standard models infer upstream/downstream
relations of signalling genes. B-NEMs in addition resolve the
Boolean logic of signal propagation. They distinguishing between
the independent activation of a protein by multiple upstream
proteins and the joint activation by a complex formed from
the upstream proteins. Moreover, B-NEMs distinguish between
activating and inhibiting interactions. Due to identifiability
problems associated with the estimation of Boolean networks, B-
NEM modelling must build on strong prior assumptions on the
network structure. Networks cannot be constructed from scratch,
but unknown features of existing networks can be resolved. We
demonstrated this idea by resolving the role of PI3K and TAK1
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as mediators of BCR signalling. In our cancer derived cell lines
signalling was perturbed. Such cancer derived changes in signalling
mechanisms can be further characterised in a comparative B-NEM
analysis of signalling in primary healthy cells and tumor derived cell
lines.
B-NEM exploits combinatorial perturbations of multiple genes.
Since it is in general not feasible to perform all possible
combinations, a subset needs to be chosen. We suggest an iterative
procedure. First a B-NEM is learned from single gene perturbations.
In case high scoring networks are incoherent with respect to
an important pathway feature, one can simulate combinatorial
perturbation data from these high scoring networks aiming at
identifying those combinations that resolve the incoherence.
In simulations we showed that B-NEMs identify the correct score
equivalence class of a signalling pathway with high accuracy.
Identifying the correct signalling topology is harder. The most
critical step here is the use of prior knowledge. We implement prior
knowledge by excluding hyper-edges. A full Bayesian framework
allows using softer priors that specify prior distributions on the full
space of network topologies. However, for large networks these
are not practical with B-NEM because a reduction of the search
space is needed for computational reasons. The a priori restriction
of the search space is needed for at least three independent reasons.
First, the search space needs to be reduced in order to achieve
practical running times of the algorithm. Second, together with
the regularizing penalty for overly complex networks the PKN is
used to limit over-fitting. Third, PKNs limit network ambiguities
due to score equivalence of multiple networks. Fortunately, these
goals are not opposing. The stronger the prior assumptions, the
faster the algorithm, the less over-fitting we have, and the fewer the
ambiguities due to score equivalence. On the other side, incorrect
a priori assumptions can be disastrous as well. They lead to biased
and under-fitted network models. Therefore one must find a good
balance between belief in prior knowledge from literature and the
data.
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